NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹315 Cr | ₹283 Cr | ₹252 Cr | ₹241 Cr | ₹118 Cr |
What is the latest Total Expenditure of NATH BIOGENES (INDIA) ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹315 Cr |
| Mar2024 | ₹283 Cr |
| Mar2023 | ₹252 Cr |
| Mar2022 | ₹241 Cr |
| Mar2013 | ₹118 Cr |
How is Total Expenditure of NATH BIOGENES (INDIA) Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹315 Cr | 11.42 | |
| Mar2024 | ₹283 Cr | 12.00 | |
| Mar2023 | ₹252 Cr | 4.66 | |
| Mar2022 | ₹241 Cr | 104.70 | |
| Mar2013 | ₹118 Cr | - | |
Compare Total Expenditure of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹272.7 Cr | -3.5% | -6.1% | -6.9% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,752.5 Cr | -3.9% | -15.5% | -11.5% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,941.3 Cr | -0.4% | -8.6% | -22.2% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,857.2 Cr | -3% | -13.1% | -24% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹845.5 Cr | -5.5% | -13.6% | -36.6% | Stock Analytics | |
| INDO US BIOTECH | ₹213.7 Cr | 3.4% | -22.3% | -47.1% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -3.5% |
-6.1% |
-6.9% |
| SENSEX | -0.2% |
-7.2% |
3.5% |
You may also like the below Video Courses